MSA trial near completion: Hi I am new... - Multiple System A...

Multiple System Atrophy Trust

1,820 members1,465 posts

MSA trial near completion

Downhillracer profile image
5 Replies

Hi I am new here and I have MSA. I have been searching for all the info I can find. No real drugs to even slow this. I have read B vitamins are helpful' Possible good news, recently a team from Vanderbilt University in the US released interim results from a small study of their drug ATH434 at 6 months.

43% of patients showed improvement on UMSARS activities of daily living scale

29% had stable or improved neurological symptoms

No safety issues

This is just a tiny open label trial, so cannot be considered as any sort of proof.

They have another trial running which is a larger double blind trial, complete in November on earlier stage MSA. Reporting results Jan next year. That is ATH434-201 Phase 2. That could be interesting because all the improvers in the open label study were early stage. Fingers crossed.

Written by
Downhillracer profile image
Downhillracer
To view profiles and participate in discussions please or .
Read more about...
5 Replies
Gill-C profile image
Gill-C

Got to keep looking forwards! Thank you for the information

Gill

Monkeyfeet1 profile image
Monkeyfeet1

thank you for the information xx

Worbs2 profile image
Worbs2

They talked about 3 phase in summer of 2025. I was in ATH434-201 Trial. Hopeful,Ron, MSA-C PATIENT

Downhillracer profile image
Downhillracer in reply toWorbs2

i hope it did you some good. I am still early stage. These guys have been working with different metal chelators on neuro diseases for decades. In this case they did ATH434 animal studies on several neuro disease and MSA was a standout. That is why they went after MSA with the 201 (your study) first and why I am optimistic for success. The promising recent data reported from the 202 open label makes me very confident of some success, finally. But I have been wrong before:-)

Downhillracer profile image
Downhillracer in reply toWorbs2

They just announced the 201 trial is complete. Now they have to lock the data and crunch the numbers with top line results due late Jan or early Feb. Their drug, ATH 434 is an iron chelator. Other stronger iron chelators have been trialed and failed. This drug is looking for the sweet spot, where it can remove labile(free) iron from neurons, but is not strong enough out compete the cells for the iron they need. Tests in primates and the small open label (no placebo to compare) suggest they are on the right track. The theory is that excess iron is what causes the alpha-synuclein to clump and cause the problem. This trial is in early stage <4 yrs patients. Fingers crossed.

Not what you're looking for?

You may also like...

Advanced MSA / Towards the end

Like so much to do with MSA, this is a difficult subject to write about. My wife, just turned 60,...

MSA medication

My husband was diagnosed with MSA in July and was started on Sinemet straight away. In all this...
Redjune1 profile image

MSA Clinics

👋 everyone, hope you're all as well as can be expected and looking forward to Christmas.Please...
Frenchoak profile image

MSA Trust Community Guidelines

Welcome to the MSA Trust Community at HealthUnlocked! The goal of our community is to provide an...
EmmaMSA profile image
Partner

MSA Trial in early stage <4yrs patients completed. Company is now in trading halt

The trial finished in Nov, the data crunching must be complete, the company has gone into a trading...

Moderation team

See all
JamesMSAT profile image
JamesMSATAdministrator
MSATKirsten profile image
MSATKirstenAdministrator
MSAAndy profile image
MSAAndyAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.